Market Updates
Danaher Quarterly Revenues Advanced 12%, Net Income Up 1%
Scott Peters
23 Apr, 2022
New York City
Danaher Corp said first quarter 2022 net revenues increased 12% to $7.7 billion, net income increased 1% to $1.7 billion, and diluted earnings per share $2.31 compared to $2.29 a year ago.
COVID-19 related testing drove sales higher by 4%.
Operating margins declined 80 basis points to 28.3% from 29.1% in the quarter a year ago.
Life Sciences segment revenues rose 9.5% to $3.9 billion and operating profit margin declined 370 basis points to 28.8%.
Diagnostics segment revenues increased 21.5% to $2.6 billion and operating margin improved 480 basis points to 33.5%.
Environmental & Applied Solutions segment revenues rose 2.5% to $1.16 billion and operating margin fell 480 basis points to 20.3%.
The Washington, D.C. based conglomerate manufactures industrial, medical and commercial products including leading brands Beckman Coulter, Leica, and Sciex.
Guidance and Outlook
The company guided non-GAAP base business core revenues growth which excluding acquisitions and currency translations in the second quarter in the mid-single digit percent range, which includes an approximately 200 to 300 basis point headwind from the COVID-19 related shutdowns in China.
For the full year 2022, the company continues to expect non-GAAP base business core revenue growth will be in the high-single digit percent range.
Annual Returns
| Company | Ticker | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|
Earnings
| Company | Ticker | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|